Lisa Sher | Senior Director of Investor Relations and Communications |
Roger Crystal | Chief Executive Officer |
David O'Toole | Chief Financial Officer |
Brandon Folkes | Cantor Fitzgerald |
Carl Byrnes | Northland Capital Market |
Greetings, and welcome to the Opiant Pharmaceuticals Second Quarter 2019 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Lisa Sher, Senior Director of Investor Relations and Communications. Please go ahead.
Thank you, operator, and thank you all for joining us this afternoon.